Nothing Special   »   [go: up one dir, main page]

NO772958L - Fremgangsmaate ved fremstilling av 0-(3-amino-2-hydroxy-propyl)-amidoximderivater - Google Patents

Fremgangsmaate ved fremstilling av 0-(3-amino-2-hydroxy-propyl)-amidoximderivater

Info

Publication number
NO772958L
NO772958L NO772958A NO772958A NO772958L NO 772958 L NO772958 L NO 772958L NO 772958 A NO772958 A NO 772958A NO 772958 A NO772958 A NO 772958A NO 772958 L NO772958 L NO 772958L
Authority
NO
Norway
Prior art keywords
amidoximi
propyl
hydroxy
procedures
derivatives
Prior art date
Application number
NO772958A
Other languages
English (en)
Other versions
NO144793C (no
NO144793B (no
Inventor
Kalman Takacs
Peter Literati Nagy
Ilona Nee Ajzert Kiss
Antal Simay
Matyas Szentivanyi
Sandor Virag
Katalin Farago
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of NO772958L publication Critical patent/NO772958L/no
Publication of NO144793B publication Critical patent/NO144793B/no
Publication of NO144793C publication Critical patent/NO144793C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/12Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines
    • C07C259/14Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. N-hydroxyamidines having carbon atoms of hydroxamidine groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO772958A 1976-08-27 1977-08-26 Analogifremgangsmaate ved fremstilling av o-(3-amino-2-hydroxypropyl)-amidoximderivater NO144793C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU76CI1682A HU177578B (en) 1976-08-27 1976-08-27 Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives

Publications (3)

Publication Number Publication Date
NO772958L true NO772958L (no) 1978-02-28
NO144793B NO144793B (no) 1981-08-03
NO144793C NO144793C (no) 1981-11-11

Family

ID=10994625

Family Applications (1)

Application Number Title Priority Date Filing Date
NO772958A NO144793C (no) 1976-08-27 1977-08-26 Analogifremgangsmaate ved fremstilling av o-(3-amino-2-hydroxypropyl)-amidoximderivater

Country Status (23)

Country Link
JP (1) JPS5350131A (no)
AT (1) AT355554B (no)
AU (1) AU521432B2 (no)
BE (1) BE858134A (no)
CA (1) CA1077506A (no)
CH (1) CH630344A5 (no)
CS (1) CS204008B2 (no)
DD (1) DD132433A5 (no)
DE (1) DE2738589A1 (no)
DK (1) DK150196C (no)
ES (1) ES462346A1 (no)
FI (1) FI68396C (no)
FR (1) FR2362845A1 (no)
GB (1) GB1582029A (no)
GR (1) GR63623B (no)
HU (1) HU177578B (no)
IL (1) IL52804A (no)
NL (1) NL187478C (no)
NO (1) NO144793C (no)
PL (1) PL107628B1 (no)
SE (1) SE435280B (no)
SU (1) SU730296A3 (no)
YU (2) YU202377A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849522A (en) * 1983-11-03 1989-07-18 Merrell Dow Pharmaceuticals Novel alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
ZA848428B (en) * 1983-11-03 1985-06-26 Merrell Pharma Inc Novel alkoxyimino ether derivatives of 5-acyl-2(1h)-pyridiones
US5212314A (en) * 1983-11-03 1993-05-18 Merrell Dow Pharmaceuticals Inc. Alkoxyimino ether derivatives of 5-acyl-2(1H)-pyridinones
JPH01169445A (ja) * 1987-12-25 1989-07-04 Fuji Photo Film Co Ltd 焦点距離切換えカメラ
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
PL344002A1 (en) 1998-05-11 2001-09-10 Takeda Chemical Industries Ltd Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
AU5296799A (en) * 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
AU2003202104B8 (en) 2002-01-11 2008-10-02 Cytrx Corporation Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
MX2023005954A (es) 2020-11-19 2023-09-04 Zevra Denmark As Procesos para preparar citrato de arimoclomol e intermediarios del mismo.

Also Published As

Publication number Publication date
GR63623B (en) 1979-11-27
YU237782A (en) 1983-12-31
DK150196B (da) 1987-01-05
IL52804A (en) 1981-06-29
AT355554B (de) 1980-03-10
DK150196C (da) 1987-07-06
DK379777A (da) 1978-02-28
SE435280B (sv) 1984-09-17
NO144793C (no) 1981-11-11
FI68396C (fi) 1985-09-10
CA1077506A (en) 1980-05-13
NL7709276A (nl) 1978-03-01
FI68396B (fi) 1985-05-31
PL107628B1 (pl) 1980-02-29
BE858134A (fr) 1977-12-16
FR2362845A1 (fr) 1978-03-24
GB1582029A (en) 1980-12-31
DE2738589A1 (de) 1978-03-02
HU177578B (en) 1981-11-28
ES462346A1 (es) 1978-06-16
JPS5350131A (en) 1978-05-08
DD132433A5 (de) 1978-09-27
AU521432B2 (en) 1982-04-01
NO144793B (no) 1981-08-03
AU2825477A (en) 1979-03-01
FR2362845B1 (no) 1981-01-09
SU730296A3 (ru) 1980-04-25
NL187478C (nl) 1991-10-16
FI772551A (fi) 1978-02-28
YU202377A (en) 1983-12-31
ATA605477A (de) 1979-08-15
CH630344A5 (en) 1982-06-15
IL52804A0 (en) 1977-10-31
JPS6216942B2 (no) 1987-04-15
SE7709482L (sv) 1978-02-28
CS204008B2 (en) 1981-03-31

Similar Documents

Publication Publication Date Title
NO148281C (no) Fremgangsmaate ved fremstilling av allergenholdige forbindelser
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
NO772958L (no) Fremgangsmaate ved fremstilling av 0-(3-amino-2-hydroxy-propyl)-amidoximderivater
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821847L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
NO774440L (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenylalaninmethylester
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
NO146656C (no) Fremgangsmaate ved fremstilling av xylitolholdige drops
NO783185L (no) Fremgangsmaate ved fremstilling av serinol
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
NO773761L (no) Fremgangsmaate ved fremstilling av urea
NO772889L (no) Fremgangsmaate ved fremstilling av dietnaeringsmiddel
NO143346C (no) Fremgangsmaate ved fremstilling av thymosin alfa1
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
NO770836L (no) Fremgangsm}te ved fremstilling av alkalicellulose
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat